Supplement and drug interactions

Interactions with medications described in the NIH Office of Dietary Supplements (ODS) Health Professional fact sheets. Each drug links to its page in the ClinDose drug library.

Vitamin K food guide for warfarinVitamin K per portion for everyday foods, with tips for keeping intake consistent
  • Warfarin (Coumadin) and similar anticoagulants

    Vitamin K can have a serious and potentially dangerous interaction with anticoagulants such as warfarin (Coumadin) as well as phenprocoumon, acenocoumarol, and tioclomarol, which are commonly used in some European countries. People who are taking warfarin and similar anticoagulants need to maintain a consistent intake of vitamin K from food and supplements because sudden changes in vitamin K intakes can increase or decrease the anticoagulant effect.

  • Antibiotics

    Antibiotics can destroy vitamin K-producing bacteria in the gut, potentially decreasing vitamin K status. This effect might be more pronounced with cephalosporin antibiotics, such as cefoperazone (Cefobid), because these antibiotics might also inhibit the action of vitamin K in the body.

  • Bile acid sequestrants

    Bile acid sequestrants, such as cholestyramine (Questran) and colestipol (Colestid), are used to reduce cholesterol levels by preventing reabsorption of bile acids. They can also reduce the absorption of vitamin K and other fat-soluble vitamins, although the clinical significance of this effect is not clear.

  • Orlistat

    Orlistat is a weight-loss drug that is available as both an over-the-counter (Alli) and prescription (Xenical) medication. It reduces the body's absorption of dietary fat and in doing so, it can also reduce the absorption of fat-soluble vitamins, such as vitamin K.

  • Anticoagulant and antiplatelet medications

    Vitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors. As a result, taking large doses of vitamin E with anticoagulant or antiplatelet medications, such as warfarin (Coumadin), can increase the risk of bleeding, especially in conjunction with low vitamin K intake.

  • Simvastatin and niacin

    Some people take vitamin E supplements with other antioxidants, such as vitamin C, selenium, and beta-carotene. This collection of antioxidant ingredients blunted the rise in high-density lipoprotein (HDL) cholesterol levels among people who were treated with a combination of simvastatin (brand name Zocor) and niacin.

  • Chemotherapy and radiotherapy

    Oncologists generally advise against the use of antioxidant supplements during cancer chemotherapy or radiotherapy because they might reduce the effectiveness of these therapies by inhibiting cellular oxidative damage in cancerous cells. Although a systematic review of randomized controlled trials has called this concern into question, further research is needed to evaluate the potential risks and benefits of concurrent antioxidant supplementation with conventional therapies…

    No matching drug in the library.

  • Retinoids

    Several synthetic retinoids derived from vitamin A are used orally as prescription medicines. Retinoids can increase the risk of hypervitaminosis A when taken in combination with vitamin A supplements.

  • Chemotherapy and radiation

    The safety and efficacy of using vitamin C and other antioxidants during cancer treatment is controversial. Individuals who are undergoing chemotherapy or radiation should consult with their oncologist prior to taking vitamin C or other antioxidant supplements, especially in high doses.

    No matching drug in the library.

  • 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)

    Vitamin C, in combination with other antioxidants, may attenuate the increase in high-density lipoprotein levels that result from taking combination niacin/simvastatin (Zocor) therapy. Health care providers should monitor lipid levels in individuals who are taking both statins and antioxidant supplements.

  • Cycloserine

    Cycloserine (Seromycin) is a broad-spectrum antibiotic used to treat tuberculosis. In combination with pyridoxal phosphate, cycloserine increases urinary excretion of pyridoxine.

  • Antiepileptic medications

    Some antiepileptic drugs, including valproic acid (Depakene, Stavzor), carbamazepine (Carbatrol, Epitol, Tegretol, and others), and phenytoin (Dilantin) increase the catabolism rate of vitamin B6 vitamers, resulting in low plasma PLP concentrations and hyperhomocysteinemia.

  • Theophylline

    Theophylline (Aquaphyllin, Elixophyllin, Theolair, Truxophyllin, and many others) can prevent or treat shortness of breath, wheezing, and other breathing problems caused by asthma, chronic bronchitis, emphysema, and other lung diseases. Patients treated with theophylline often have low plasma PLP concentrations, which could contribute to the neurological and central nervous system side effects associated with theophylline, including seizures.

  • Methotrexate

    Methotrexate (Rheumatrex, Trexall), used to treat cancer and autoimmune diseases, is a folate antagonist. Patients taking methotrexate for cancer should consult their oncologist before taking folate supplements because the supplements could interfere with methotrexate’s anticancer effects.

  • Antiepileptic medications

    Antiepileptic medications, such as phenytoin (Dilantin), carbamazepine (Carbatrol, Tegretol, Equetro, Epitol), and valproate (Depacon), are used to treat epilepsy, psychiatric diseases, and other medical conditions. These medications can reduce serum folate levels.

  • Sulfasalazine

    Sulfasalazine (Azulfidine) is used primarily to treat ulcerative colitis. It inhibits the intestinal absorption of folate and can cause folate deficiency.

  • Furosemide

    Furosemide (Lasix) is a loop diuretic used to treat edema and hypertension by increasing urinary output. Research has linked the use of furosemide to decreases in thiamin concentrations, possibly to deficient levels, as a result of urinary thiamin loss.

  • Chemotherapy with fluorouracil

    Fluorouracil (also known as 5-fluorouracil; Adrucil) is a chemotherapy drug that is commonly used to treat colorectal and other solid cancers. The published literature includes several cases of beriberi or Wernicke’s encephalopathy resulting from treatment with this drug, possibly because the drug might increase thiamin metabolism and block the formation of TDP, the active form of thiamin.

  • Antacids

    Antacids that contain aluminum hydroxide, such as Maalox HRF and Rulox, bind phosphorus in the intestines, and their chronic use for 3 months or longer can therefore lead to hypophosphatemia. Antacids containing calcium carbonate (Rolaids, Tums, Maalox) also decrease instestinal absorption of dietary phosphorus.

  • Laxatives

    Some laxatives, such as Fleet Prep Kit #1, contain sodium phosphate, and ingesting these products can increase serum phosphate levels. After 13 reports of deaths associated with taking one dose that was higher than recommended on the label of a laxative containing sodium phosphate, FDA issued a warning that these products are potentially dangerous if more than recommended doses are taken, especially in people with kidney disease, heart disease, or dehydration.

    No matching drug in the library.

  • Cisplatin

    Cisplatin, an inorganic platinum chemotherapy agent, is used to treat ovarian, bladder, lung, and other cancers. Cisplatin can reduce selenium levels in hair and serum but whether these reductions have a clinically significant impact is not known.

Omega-3 fatty acids (fish oil)

ODS fact sheet, updated Aug 22, 2025
  • Warfarin (Coumadin) and similar anticoagulants

    Fish oil can have antiplatelet effects at high doses, although it appears to be less potent than aspirin. The authors of a 2014 review concluded that omega-3s do not affect the risk of clinically significant bleeding, and the FDA-approved package inserts for omega-3 pharmaceuticals state that studies with omega-3s have not produced "clinically significant bleeding episodes".

Source: NIH Office of Dietary Supplements fact sheets (public domain), checked Nov 4, 2026. Drug classes named in a fact sheet (for example, proton pump inhibitors) are linked to each member drug. This list covers the ODS fact sheets only; check the drug label and an interaction checker for other supplements.